Neuphoria Therapeutics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $-15,662 | $23,874 |
Gross Profit | -165 | -250 | -15,332 | 23,610 |
EBITDA | -2,658 | -14,789 | -846,807 | 18,059 |
EBIT | -2,824 | -15,040 | -846,310 | 17,795 |
Net Income | 1,864 | -14,987 | -378,145 | 17,925 |
Net Change In Cash | 0 | 0 | -15,662 | 23,874 |
Free Cash Flow | -6,435 | -3,794 | 73,566 | 11,453 |
Cash | 22,170 | 13,649 | 21,591 | 17,045 |
Basic Shares | 4,536 | 2,246 | 1,622 | 234,011 |
Annual Financials
| Values in thousands | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
Revenue | $23,953 | $0 | $0 | $277 |
Gross Profit | 22,939 | -992 | -671 | 181 |
EBITDA | -268 | -22,331 | -21,544 | -28,027 |
EBIT | -1,282 | -23,324 | -22,215 | -29,196 |
Net Income | -565 | -23,193 | -21,646 | -22,936 |
Net Change In Cash | 23,953 | 0 | 0 | 277 |
Free Cash Flow | 77,229 | -14,681 | -9,846 | -14,966 |
Cash | 21,591 | 12,608 | 8,056 | 23,089 |
Basic Shares | 1,622 | 149,800 | 122,394 | 112,779 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0.41 |
2025-09-30 | -$4.41 |
2025-06-30 | -$5.55 |
2025-03-31 | $6.55 |
